Costello syndrome: the natural history of a true postnatal growth retardation syndrome

S Umans1, P Decock, J P Fryns

  • 1Center for Human Genetics, University of Leuven, Belgium.

Genetic Counseling (Geneva, Switzerland)
|January 1, 1995
PubMed

Insights

This case study details the 12-year natural history of Costello syndrome in a female child. It highlights key diagnostic signs and significant postnatal growth retardation.

Area of Science:

  • Pediatric Endocrinology
  • Clinical Genetics

Background:

  • Costello syndrome is a rare genetic disorder.
  • Characterized by distinctive facial features, developmental delays, and increased cancer risk.

Observation:

  • Presents the natural history of a female child with Costello syndrome from birth to 12 years.
  • Documents the progression of diagnostic clinical signs.
  • Illustrates significant postnatal growth retardation.

Findings:

  • Confirms the presence of characteristic Costello syndrome features.
  • Demonstrates the impact of the syndrome on growth trajectory.
  • Highlights the importance of early diagnosis and monitoring.

Implications:

  • Provides valuable insights into the long-term clinical course of Costello syndrome.
  • Informs clinical management strategies for affected children.
  • Contributes to understanding the phenotypic variability in Costello syndrome.

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Oxygen Requirements and Growth Patterns01:29

Oxygen Requirements and Growth Patterns

Microorganisms exhibit diverse oxygen requirements and growth patterns driven by their metabolic strategies and environmental adaptations. Oxygen, while essential for many organisms, can also be toxic under certain conditions, shaping how microorganisms grow and survive.Oxygen Requirements of MicroorganismsMicroorganisms are classified based on their ability to use or tolerate oxygen:● Obligate aerobes like Mycobacterium tuberculosis need oxygen for energy production, as it serves as the...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...